FIT-039 (C008B-265429)

FIT-039 is a selective, ATP-competitive CDK9 inhibitor with an IC50 of 5.8 μM for CKD9/cyclin T1. FIT-039 does not inhibit other CDKs and other kinases. FIT-039 inhibits replication of HSV-1 (IC50 of 0.69 μM), HSV-2, human adenovirus, and human CMV. FIT-039 is a promising antiviral agent for inhibiting drug-resistant HSVs and other DNA viruses.

CDK Inhibitors

Specifications & Purity: FIT-039 is a selective, ATP-competitive CDK9 inhibitor with an IC50 of 5.8 μM for CKD9/cyclin T1. FIT-039 does not inhibit other CDKs and other kinases. FIT-039 inhibits replication of HSV-1 (IC50 of 0.69 μM), HSV-2, human adenovirus, and human CMV. FIT-039 is a promising antiviral agent for inhibiting drug-resistant HSVs and other DNA viruses.

Grade: Moligand™

Molecular Formula: C17H18FN3S

Molecular Weight: 315.41

PubChem CID: 25186688

Isomeric SMILES: C1CCN(CC1)C2=C(C=C(C=C2)F)NC(=S)C3=CC=NC=C3

Storage Temperature: Store at -20°C

Shipped in: Ice chest + Ice pads

UPC:

51442716

Weight:

1.06 Ounces

HazmatClass:

Yes

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

F413109-100mg

Country of Origin:

China

CAS:

1113044-49-7

Product Size:

100mg

Harmonized Tariff Code:

2931.90.90